Reprint

Metabolic Syndrome

From Etiology to Prevention and Clinical Management

Edited by
January 2021
346 pages
  • ISBN978-3-03943-989-8 (Hardback)
  • ISBN978-3-03943-990-4 (PDF)

This book is a reprint of the Special Issue Metabolic Syndrome: From Etiology to Prevention and Clinical Management that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary
Metabolic syndrome has been the topic of countless publications. It still remains a subject of debate and some experts have even questioned its clinical relevance. Its diagnosis is nevertheless predictive of an increased risk of type 2 diabetes and cardiovascular disease even in the absence of traditional risk factors. Many years ago, our team made the point that the most prevalent form of metabolic syndrome was linked to abdominal obesity, which can be found even among individuals who are not considered obese by body weight standards. Imaging techniques such as computed tomography and magnetic resonance imaging have revealed the link between regional body fat partitioning and cardiometabolic risk. Visceral obesity is the most dangerous form of obesity, with subcutaneous obesity being associated with lower health risk. We have proposed that excess visceral fat may be a marker of subcutaneous adipose tissue dysfunction not being able to serve as a metabolic sink, causing lipid accumulation at undesired sites, a condition described as ectopic fat deposition. Among the effective approaches to prevent, delay, or manage metabolic syndrome, lifestyle changes are the key elements, with an emphasis on the importance of healthy global dietary patterns, regular physical activity, and adequate sleep quality.
Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
trimethylamine N-oxide (TMAO); obesity; visceral adiposity index (VAI); fatty liver index (FLI); metabolic syndrome (MetS); healthy lifestyle score; metabolic syndrome; SUN cohort; branched-chain amino acids; acylcarnitines; dietary protein sources; meat; metabolic syndrome; metabolite profiling; diet; pediatric obesity; nonalcoholic fatty liver disease; metabolic syndrome; saliva; metabolomics; gas-chromatography mass spectrometry; anthropometric indexes; diagnosis criteria; metabolic syndrome; adolescents; obesity; metabolic syndrome; bone mineral density; obesity; insulin resistance; bone health; osteoporosis; atherosclerotic cardiovascular disease; visceral fat accumulation; universal public health screening program; health check-up; health guidance; city planning; carbohydrate; polyunsaturated fat; monounsaturated fat; saturated fat; fish oil; meta-analyses; lipids; glucose; blood pressure; insulin resistance; metabolic syndrome; adolescents; breastfeeding duration; birth weight; metabolic syndrome; cardiorespiratory fitness; insulin resistance; cardiovascular disease; exercise training; linseed; secoisolariciresinol diglucoside; obesity; blood pressure; high-carbohydrate; high-fat diet; anthropometric indices; diagnosis criteria; metabolic syndrome; cardiometabolic risk; elderly; metabolic syndrome; obesity; insulin resistance; risk; pediatric; adolescent; sugar-sweetened beverages; metabolic syndrome; weight gain; type 2 diabetes; cardiovascular disease; cardiometabolic risk; older adults; macronutrient intake; dietary intake; fat intake; metabolic syndrome; endocannabinoids; endocannabinoidome; metabolic syndrome; microbiome; fructose; metabolic syndrome; hypertriglyceridemia; metabolism; metabolic syndrome; sleep; sleep apnea; sleep habit; sleep duration; chronotype; social jetlag; metabolic syndrome; ethnicity; prevention; lifestyle; cardiometabolic; exercise; abdominal obesity; energy balance; caloric restriction; non-alcoholic fatty liver disease; physical activity; saturated fatty acids; metabolic syndrome; diet quality; dietary guidelines; cardiovascular disease; n/a